Wilson Z, Odedra R, Wallez Y, Wijnhoven PWG, et al. ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib. Cancer Res 2022;82:1140-1152.
PMID: 35078817